Microfabricated Microcatheter Advantages in Middle Meningeal Artery Embolization: an Early Experience at a Single Center

Recruiting now

Conditions studied: Chronic Subdural Hematoma, Hemorrhage Brain

In brief

The purpose of this study is to evaluate the function of matched pair Aristotle 14 Guidewire and Plato Microcatheter in MMA embolization treatment for chronic subdural hematoma compared to surgeon's preference

Key facts

Study ID

NCT07324551

Run by

Ohio State University

People needed

100

Starts

2025-11-03

Expected to finish

2029-07-01

Last updated by the study team

2026-01-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years old
• Patient or legally authorized representative (LAR) signs an informed consent form
• Confirmed diagnosis of subacute or chronic subdural hematoma, defined as 50% or more chronic blood
• Pre-morbid Modified Rankin Score of ≤ 3

You may not qualify if…

• Age < 18 years old
• Potentially dangerous anatomic variations leading to increased procedural risk or unsafe access for MMA embolization
• Unmanaged, uncontrolled bleeding disorders/blood diathesis
• Presumed septic embolus, or suspicion of microbial superinfection
• Contraindication to angiography
• CT or MRI evidence of intra-cranial tumor or mass lesion

Where it is running

• The Ohio State University Wexner Medical Center — Columbus, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.